AKT1 and neoplasm: However, high levels of SIRT6 were observed in diffuse large B-cell lymphoma, and its overexpression promoted the metastasizing capacity of tumor cells and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling [17].